How does Australia’s approach to psilocybin compare to Canada, the US, and other countries loosening restrictions?
How Does Australia’s Approach to Psilocybin Compare to Canada, the US, and Other Countries Loosening Restrictions? Australia has emerged as a global leader in psychedelic reform. Since July 1, 2023, the Therapeutic Goods Administration (TGA) has reclassified psilocybin as a Schedule 8 medicine, allowing authorised psychiatrists to prescribe it for treatment-resistant depression . This makes […]